EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 138 filers reported holding EPIZYME INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,000 | -80.8% | 8,805 | -57.7% | 0.00% | – |
| Q4 2021 | $52,000 | -1.9% | 20,806 | +99.5% | 0.00% | – |
| Q3 2021 | $53,000 | +3.9% | 10,430 | +69.7% | 0.00% | – |
| Q2 2021 | $51,000 | +168.4% | 6,147 | +175.2% | 0.00% | – |
| Q1 2021 | $19,000 | +18.8% | 2,234 | +47.0% | 0.00% | – |
| Q4 2020 | $16,000 | – | 1,520 | +50566.7% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 3 | -98.3% | 0.00% | – |
| Q2 2020 | $3,000 | -57.1% | 177 | -56.5% | 0.00% | – |
| Q1 2020 | $7,000 | -87.9% | 407 | -82.7% | 0.00% | – |
| Q4 2019 | $58,000 | +5700.0% | 2,355 | +4610.0% | 0.00% | – |
| Q3 2019 | $1,000 | -91.7% | 50 | -94.6% | 0.00% | – |
| Q2 2019 | $12,000 | +9.1% | 932 | +1.9% | 0.00% | – |
| Q1 2019 | $11,000 | +120.0% | 915 | +2.9% | 0.00% | – |
| Q4 2018 | $5,000 | -83.9% | 889 | -69.0% | 0.00% | – |
| Q3 2018 | $31,000 | +93.8% | 2,870 | +142.0% | 0.00% | – |
| Q2 2018 | $16,000 | 0.0% | 1,186 | +34.8% | 0.00% | – |
| Q1 2018 | $16,000 | -27.3% | 880 | -48.4% | 0.00% | – |
| Q4 2017 | $22,000 | -78.4% | 1,705 | -68.0% | 0.00% | – |
| Q3 2017 | $102,000 | +251.7% | 5,336 | +172.9% | 0.00% | – |
| Q2 2017 | $29,000 | -67.8% | 1,955 | -62.9% | 0.00% | – |
| Q1 2017 | $90,000 | +8.4% | 5,269 | -24.0% | 0.00% | – |
| Q4 2016 | $83,000 | +80.4% | 6,934 | +48.2% | 0.00% | – |
| Q3 2016 | $46,000 | -4.2% | 4,680 | 0.0% | 0.00% | – |
| Q2 2016 | $48,000 | -18.6% | 4,680 | -3.1% | 0.00% | – |
| Q1 2016 | $59,000 | -22.4% | 4,832 | +2.0% | 0.00% | – |
| Q4 2015 | $76,000 | -2.6% | 4,738 | -22.6% | 0.00% | – |
| Q3 2015 | $78,000 | +1200.0% | 6,123 | +1690.4% | 0.00% | – |
| Q1 2015 | $6,000 | 0.0% | 342 | +14.4% | 0.00% | – |
| Q4 2014 | $6,000 | – | 299 | +2200.0% | 0.00% | – |
| Q2 2014 | $0 | – | 13 | -40.9% | 0.00% | – |
| Q1 2014 | $0 | – | 22 | +22.2% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 18 | -90.5% | 0.00% | – |
| Q3 2013 | $8,000 | +166.7% | 189 | +61.5% | 0.00% | – |
| Q2 2013 | $3,000 | – | 117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |